Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Anti-Emetic Drug Market Growth 2022-2028

  • LP 4822563
  • 114 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Anti-Emetic Drug will have significant change from previous year. According to our (LP Information) latest study, the global Anti-Emetic Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Anti-Emetic Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Anti-Emetic Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Emetic Drug market, reaching US$ million by the year 2028. As for the Europe Anti-Emetic Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Anti-Emetic Drug players cover Merck, Novartis, Glenmark Pharmaceuticals, and F. Hoffmann-La Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Emetic Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral

Injection

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Home Care

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Novartis

Glenmark Pharmaceuticals

F. Hoffmann-La Roche

Heron Therapeutics

Kyowa Kirin

Aurobindo Pharma

Mylan

Hikma

Akorn

Dr. Reddy’s Laboratories

Cipla

Fresenius Kabi

Wockhardt

Sun Pharmaceutical Industries

Teva Pharmaceutical

Pfizer

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Emetic Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-Emetic Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-Emetic Drug by Country/Region, 2017, 2022 & 2028

2.2 Anti-Emetic Drug Segment by Type

2.2.1 Oral

2.2.2 Injection

2.2.3 Others

2.3 Anti-Emetic Drug Sales by Type

2.3.1 Global Anti-Emetic Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-Emetic Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-Emetic Drug Sale Price by Type (2017-2022)

2.4 Anti-Emetic Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Home Care

2.4.4 Others

2.5 Anti-Emetic Drug Sales by Application

2.5.1 Global Anti-Emetic Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-Emetic Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-Emetic Drug Sale Price by Application (2017-2022)

3 Global Anti-Emetic Drug by Company

3.1 Global Anti-Emetic Drug Breakdown Data by Company

3.1.1 Global Anti-Emetic Drug Annual Sales by Company (2020-2022)

3.1.2 Global Anti-Emetic Drug Sales Market Share by Company (2020-2022)

3.2 Global Anti-Emetic Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-Emetic Drug Revenue by Company (2020-2022)

3.2.2 Global Anti-Emetic Drug Revenue Market Share by Company (2020-2022)

3.3 Global Anti-Emetic Drug Sale Price by Company

3.4 Key Manufacturers Anti-Emetic Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-Emetic Drug Product Location Distribution

3.4.2 Players Anti-Emetic Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Emetic Drug by Geographic Region

4.1 World Historic Anti-Emetic Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-Emetic Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-Emetic Drug Annual Revenue by Geographic Region

4.2 World Historic Anti-Emetic Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-Emetic Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-Emetic Drug Annual Revenue by Country/Region

4.3 Americas Anti-Emetic Drug Sales Growth

4.4 APAC Anti-Emetic Drug Sales Growth

4.5 Europe Anti-Emetic Drug Sales Growth

4.6 Middle East & Africa Anti-Emetic Drug Sales Growth

5 Americas

5.1 Americas Anti-Emetic Drug Sales by Country

5.1.1 Americas Anti-Emetic Drug Sales by Country (2017-2022)

5.1.2 Americas Anti-Emetic Drug Revenue by Country (2017-2022)

5.2 Americas Anti-Emetic Drug Sales by Type

5.3 Americas Anti-Emetic Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Emetic Drug Sales by Region

6.1.1 APAC Anti-Emetic Drug Sales by Region (2017-2022)

6.1.2 APAC Anti-Emetic Drug Revenue by Region (2017-2022)

6.2 APAC Anti-Emetic Drug Sales by Type

6.3 APAC Anti-Emetic Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-Emetic Drug by Country

7.1.1 Europe Anti-Emetic Drug Sales by Country (2017-2022)

7.1.2 Europe Anti-Emetic Drug Revenue by Country (2017-2022)

7.2 Europe Anti-Emetic Drug Sales by Type

7.3 Europe Anti-Emetic Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Emetic Drug by Country

8.1.1 Middle East & Africa Anti-Emetic Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-Emetic Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-Emetic Drug Sales by Type

8.3 Middle East & Africa Anti-Emetic Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-Emetic Drug

10.3 Manufacturing Process Analysis of Anti-Emetic Drug

10.4 Industry Chain Structure of Anti-Emetic Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-Emetic Drug Distributors

11.3 Anti-Emetic Drug Customer

12 World Forecast Review for Anti-Emetic Drug by Geographic Region

12.1 Global Anti-Emetic Drug Market Size Forecast by Region

12.1.1 Global Anti-Emetic Drug Forecast by Region (2023-2028)

12.1.2 Global Anti-Emetic Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-Emetic Drug Forecast by Type

12.7 Global Anti-Emetic Drug Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Anti-Emetic Drug Product Offered

13.1.3 Merck Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis Anti-Emetic Drug Product Offered

13.2.3 Novartis Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Glenmark Pharmaceuticals

13.3.1 Glenmark Pharmaceuticals Company Information

13.3.2 Glenmark Pharmaceuticals Anti-Emetic Drug Product Offered

13.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Glenmark Pharmaceuticals Main Business Overview

13.3.5 Glenmark Pharmaceuticals Latest Developments

13.4 F. Hoffmann-La Roche

13.4.1 F. Hoffmann-La Roche Company Information

13.4.2 F. Hoffmann-La Roche Anti-Emetic Drug Product Offered

13.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 F. Hoffmann-La Roche Main Business Overview

13.4.5 F. Hoffmann-La Roche Latest Developments

13.5 Heron Therapeutics

13.5.1 Heron Therapeutics Company Information

13.5.2 Heron Therapeutics Anti-Emetic Drug Product Offered

13.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Heron Therapeutics Main Business Overview

13.5.5 Heron Therapeutics Latest Developments

13.6 Kyowa Kirin

13.6.1 Kyowa Kirin Company Information

13.6.2 Kyowa Kirin Anti-Emetic Drug Product Offered

13.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Kyowa Kirin Main Business Overview

13.6.5 Kyowa Kirin Latest Developments

13.7 Aurobindo Pharma

13.7.1 Aurobindo Pharma Company Information

13.7.2 Aurobindo Pharma Anti-Emetic Drug Product Offered

13.7.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Aurobindo Pharma Main Business Overview

13.7.5 Aurobindo Pharma Latest Developments

13.8 Mylan

13.8.1 Mylan Company Information

13.8.2 Mylan Anti-Emetic Drug Product Offered

13.8.3 Mylan Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mylan Main Business Overview

13.8.5 Mylan Latest Developments

13.9 Hikma

13.9.1 Hikma Company Information

13.9.2 Hikma Anti-Emetic Drug Product Offered

13.9.3 Hikma Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hikma Main Business Overview

13.9.5 Hikma Latest Developments

13.10 Akorn

13.10.1 Akorn Company Information

13.10.2 Akorn Anti-Emetic Drug Product Offered

13.10.3 Akorn Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Akorn Main Business Overview

13.10.5 Akorn Latest Developments

13.11 Dr. Reddy’s Laboratories

13.11.1 Dr. Reddy’s Laboratories Company Information

13.11.2 Dr. Reddy’s Laboratories Anti-Emetic Drug Product Offered

13.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Dr. Reddy’s Laboratories Main Business Overview

13.11.5 Dr. Reddy’s Laboratories Latest Developments

13.12 Cipla

13.12.1 Cipla Company Information

13.12.2 Cipla Anti-Emetic Drug Product Offered

13.12.3 Cipla Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Cipla Main Business Overview

13.12.5 Cipla Latest Developments

13.13 Fresenius Kabi

13.13.1 Fresenius Kabi Company Information

13.13.2 Fresenius Kabi Anti-Emetic Drug Product Offered

13.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Fresenius Kabi Main Business Overview

13.13.5 Fresenius Kabi Latest Developments

13.14 Wockhardt

13.14.1 Wockhardt Company Information

13.14.2 Wockhardt Anti-Emetic Drug Product Offered

13.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Wockhardt Main Business Overview

13.14.5 Wockhardt Latest Developments

13.15 Sun Pharmaceutical Industries

13.15.1 Sun Pharmaceutical Industries Company Information

13.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Product Offered

13.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Sun Pharmaceutical Industries Main Business Overview

13.15.5 Sun Pharmaceutical Industries Latest Developments

13.16 Teva Pharmaceutical

13.16.1 Teva Pharmaceutical Company Information

13.16.2 Teva Pharmaceutical Anti-Emetic Drug Product Offered

13.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Teva Pharmaceutical Main Business Overview

13.16.5 Teva Pharmaceutical Latest Developments

13.17 Pfizer

13.17.1 Pfizer Company Information

13.17.2 Pfizer Anti-Emetic Drug Product Offered

13.17.3 Pfizer Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Pfizer Main Business Overview

13.17.5 Pfizer Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Anti-Emetic Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-Emetic Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Injection

Table 5. Major Players of Others

Table 6. Global Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)

Table 7. Global Anti-Emetic Drug Sales Market Share by Type (2017-2022)

Table 8. Global Anti-Emetic Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Anti-Emetic Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Anti-Emetic Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)

Table 12. Global Anti-Emetic Drug Sales Market Share by Application (2017-2022)

Table 13. Global Anti-Emetic Drug Revenue by Application (2017-2022)

Table 14. Global Anti-Emetic Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Anti-Emetic Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Anti-Emetic Drug Sales by Company (2020-2022) & (K Units)

Table 17. Global Anti-Emetic Drug Sales Market Share by Company (2020-2022)

Table 18. Global Anti-Emetic Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Anti-Emetic Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Anti-Emetic Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Anti-Emetic Drug Producing Area Distribution and Sales Area

Table 22. Players Anti-Emetic Drug Products Offered

Table 23. Anti-Emetic Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Anti-Emetic Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Anti-Emetic Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Anti-Emetic Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Anti-Emetic Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Anti-Emetic Drug Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Anti-Emetic Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Anti-Emetic Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Anti-Emetic Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)

Table 35. Americas Anti-Emetic Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Anti-Emetic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Anti-Emetic Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)

Table 39. Americas Anti-Emetic Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)

Table 41. Americas Anti-Emetic Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Anti-Emetic Drug Sales by Region (2017-2022) & (K Units)

Table 43. APAC Anti-Emetic Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Anti-Emetic Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Anti-Emetic Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)

Table 47. APAC Anti-Emetic Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)

Table 49. APAC Anti-Emetic Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)

Table 51. Europe Anti-Emetic Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Anti-Emetic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Anti-Emetic Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)

Table 55. Europe Anti-Emetic Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)

Table 57. Europe Anti-Emetic Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Anti-Emetic Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Anti-Emetic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Anti-Emetic Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Anti-Emetic Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Anti-Emetic Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Anti-Emetic Drug

Table 67. Key Market Challenges & Risks of Anti-Emetic Drug

Table 68. Key Industry Trends of Anti-Emetic Drug

Table 69. Anti-Emetic Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Anti-Emetic Drug Distributors List

Table 72. Anti-Emetic Drug Customer List

Table 73. Global Anti-Emetic Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Anti-Emetic Drug Sales Market Forecast by Region

Table 75. Global Anti-Emetic Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Anti-Emetic Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Anti-Emetic Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Anti-Emetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Anti-Emetic Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Anti-Emetic Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Anti-Emetic Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Anti-Emetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Anti-Emetic Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Anti-Emetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Anti-Emetic Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Anti-Emetic Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Anti-Emetic Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Anti-Emetic Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Anti-Emetic Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Anti-Emetic Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Anti-Emetic Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Anti-Emetic Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck Anti-Emetic Drug Product Offered

Table 95. Merck Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. Novartis Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Novartis Anti-Emetic Drug Product Offered

Table 100. Novartis Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Novartis Main Business

Table 102. Novartis Latest Developments

Table 103. Glenmark Pharmaceuticals Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. Glenmark Pharmaceuticals Anti-Emetic Drug Product Offered

Table 105. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Glenmark Pharmaceuticals Main Business

Table 107. Glenmark Pharmaceuticals Latest Developments

Table 108. F. Hoffmann-La Roche Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. F. Hoffmann-La Roche Anti-Emetic Drug Product Offered

Table 110. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. F. Hoffmann-La Roche Main Business

Table 112. F. Hoffmann-La Roche Latest Developments

Table 113. Heron Therapeutics Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. Heron Therapeutics Anti-Emetic Drug Product Offered

Table 115. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Heron Therapeutics Main Business

Table 117. Heron Therapeutics Latest Developments

Table 118. Kyowa Kirin Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Kyowa Kirin Anti-Emetic Drug Product Offered

Table 120. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Kyowa Kirin Main Business

Table 122. Kyowa Kirin Latest Developments

Table 123. Aurobindo Pharma Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Aurobindo Pharma Anti-Emetic Drug Product Offered

Table 125. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Aurobindo Pharma Main Business

Table 127. Aurobindo Pharma Latest Developments

Table 128. Mylan Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. Mylan Anti-Emetic Drug Product Offered

Table 130. Mylan Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Mylan Main Business

Table 132. Mylan Latest Developments

Table 133. Hikma Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. Hikma Anti-Emetic Drug Product Offered

Table 135. Hikma Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Hikma Main Business

Table 137. Hikma Latest Developments

Table 138. Akorn Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 139. Akorn Anti-Emetic Drug Product Offered

Table 140. Akorn Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Akorn Main Business

Table 142. Akorn Latest Developments

Table 143. Dr. Reddy’s Laboratories Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 144. Dr. Reddy’s Laboratories Anti-Emetic Drug Product Offered

Table 145. Dr. Reddy’s Laboratories Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Dr. Reddy’s Laboratories Main Business

Table 147. Dr. Reddy’s Laboratories Latest Developments

Table 148. Cipla Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 149. Cipla Anti-Emetic Drug Product Offered

Table 150. Cipla Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Cipla Main Business

Table 152. Cipla Latest Developments

Table 153. Fresenius Kabi Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 154. Fresenius Kabi Anti-Emetic Drug Product Offered

Table 155. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Fresenius Kabi Main Business

Table 157. Fresenius Kabi Latest Developments

Table 158. Wockhardt Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 159. Wockhardt Anti-Emetic Drug Product Offered

Table 160. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Wockhardt Main Business

Table 162. Wockhardt Latest Developments

Table 163. Sun Pharmaceutical Industries Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 164. Sun Pharmaceutical Industries Anti-Emetic Drug Product Offered

Table 165. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Sun Pharmaceutical Industries Main Business

Table 167. Sun Pharmaceutical Industries Latest Developments

Table 168. Teva Pharmaceutical Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 169. Teva Pharmaceutical Anti-Emetic Drug Product Offered

Table 170. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Teva Pharmaceutical Main Business

Table 172. Teva Pharmaceutical Latest Developments

Table 173. Pfizer Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 174. Pfizer Anti-Emetic Drug Product Offered

Table 175. Pfizer Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. Pfizer Main Business

Table 177. Pfizer Latest Developments

List of Figures

Figure 1. Picture of Anti-Emetic Drug

Figure 2. Anti-Emetic Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-Emetic Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti-Emetic Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-Emetic Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Injection

Figure 11. Product Picture of Others

Figure 12. Global Anti-Emetic Drug Sales Market Share by Type in 2021

Figure 13. Global Anti-Emetic Drug Revenue Market Share by Type (2017-2022)

Figure 14. Anti-Emetic Drug Consumed in Hospital

Figure 15. Global Anti-Emetic Drug Market: Hospital (2017-2022) & (K Units)

Figure 16. Anti-Emetic Drug Consumed in Clinic

Figure 17. Global Anti-Emetic Drug Market: Clinic (2017-2022) & (K Units)

Figure 18. Anti-Emetic Drug Consumed in Home Care

Figure 19. Global Anti-Emetic Drug Market: Home Care (2017-2022) & (K Units)

Figure 20. Anti-Emetic Drug Consumed in Others

Figure 21. Global Anti-Emetic Drug Market: Others (2017-2022) & (K Units)

Figure 22. Global Anti-Emetic Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Anti-Emetic Drug Revenue Market Share by Application in 2021

Figure 24. Anti-Emetic Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Anti-Emetic Drug Revenue Market Share by Company in 2021

Figure 26. Global Anti-Emetic Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Anti-Emetic Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Anti-Emetic Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Anti-Emetic Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Anti-Emetic Drug Sales 2017-2022 (K Units)

Figure 31. Americas Anti-Emetic Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Anti-Emetic Drug Sales 2017-2022 (K Units)

Figure 33. APAC Anti-Emetic Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Anti-Emetic Drug Sales 2017-2022 (K Units)

Figure 35. Europe Anti-Emetic Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Anti-Emetic Drug Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Anti-Emetic Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Anti-Emetic Drug Sales Market Share by Country in 2021

Figure 39. Americas Anti-Emetic Drug Revenue Market Share by Country in 2021

Figure 40. United States Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Anti-Emetic Drug Sales Market Share by Region in 2021

Figure 45. APAC Anti-Emetic Drug Revenue Market Share by Regions in 2021

Figure 46. China Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Anti-Emetic Drug Sales Market Share by Country in 2021

Figure 53. Europe Anti-Emetic Drug Revenue Market Share by Country in 2021

Figure 54. Germany Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Anti-Emetic Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Anti-Emetic Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Anti-Emetic Drug in 2021

Figure 67. Manufacturing Process Analysis of Anti-Emetic Drug

Figure 68. Industry Chain Structure of Anti-Emetic Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390